These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 8822210)

  • 21. The cell dissociation and motility triggered by scatter factor/hepatocyte growth factor are mediated through the cytoplasmic domain of the c-Met receptor.
    Komada M; Kitamura N
    Oncogene; 1993 Sep; 8(9):2381-90. PubMed ID: 7689722
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tyrosine phosphorylation of p145met mediated by EGFR and Src is required for serum-independent survival of human bladder carcinoma cells.
    Yamamoto N; Mammadova G; Song RX; Fukami Y; Sato K
    J Cell Sci; 2006 Nov; 119(Pt 22):4623-33. PubMed ID: 17062641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatocyte growth factor is the most potent endogenous stimulant of rabbit gastric epithelial cell proliferation and migration in primary culture.
    Takahashi M; Ota S; Shimada T; Hamada E; Kawabe T; Okudaira T; Matsumura M; Kaneko N; Terano A; Nakamura T
    J Clin Invest; 1995 May; 95(5):1994-2003. PubMed ID: 7738166
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of the hepatocyte growth factor/scatter factor receptor tyrosine kinase is localized to epithelia in the adult mouse.
    Yang XM; Park M
    Lab Invest; 1995 Oct; 73(4):483-91. PubMed ID: 7474919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. c-MET expression in myofibroblasts: role in autocrine activation and prognostic significance in lung adenocarcinoma.
    Tokunou M; Niki T; Eguchi K; Iba S; Tsuda H; Yamada T; Matsuno Y; Kondo H; Saitoh Y; Imamura H; Hirohashi S
    Am J Pathol; 2001 Apr; 158(4):1451-63. PubMed ID: 11290563
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumorigenesis induced by coexpression of human hepatocyte growth factor and the human met protooncogene leads to high levels of expression of the ligand and receptor.
    Rong S; Oskarsson M; Faletto D; Tsarfaty I; Resau JH; Nakamura T; Rosen E; Hopkins RF; Vande Woude GF
    Cell Growth Differ; 1993 Jul; 4(7):563-9. PubMed ID: 8398896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autocrine hepatocyte growth factor/scatter factor-Met signaling induces transformation and the invasive/metastastic phenotype in C127 cells.
    Jeffers M; Rong S; Anver M; Vande Woude GF
    Oncogene; 1996 Aug; 13(4):853-6. PubMed ID: 8761307
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiogenesis induced in vivo by hepatocyte growth factor is mediated by platelet-activating factor synthesis from macrophages.
    Camussi G; Montrucchio G; Lupia E; Soldi R; Comoglio PM; Bussolino F
    J Immunol; 1997 Feb; 158(3):1302-9. PubMed ID: 9013973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coexpression of hepatocyte growth factor and receptor (Met) in human breast carcinoma.
    Tuck AB; Park M; Sterns EE; Boag A; Elliott BE
    Am J Pathol; 1996 Jan; 148(1):225-32. PubMed ID: 8546209
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MAP kinase and beta-catenin signaling in HGF induced RPE migration.
    Liou GI; Matragoon S; Samuel S; Behzadian MA; Tsai NT; Gu X; Roon P; Hunt DM; Hunt RC; Caldwell RB; Marcus DM
    Mol Vis; 2002 Dec; 8():483-93. PubMed ID: 12500177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice.
    Kuba K; Matsumoto K; Date K; Shimura H; Tanaka M; Nakamura T
    Cancer Res; 2000 Dec; 60(23):6737-43. PubMed ID: 11118060
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The geldanamycins are potent inhibitors of the hepatocyte growth factor/scatter factor-met-urokinase plasminogen activator-plasmin proteolytic network.
    Webb CP; Hose CD; Koochekpour S; Jeffers M; Oskarsson M; Sausville E; Monks A; Vande Woude GF
    Cancer Res; 2000 Jan; 60(2):342-9. PubMed ID: 10667586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adaptor molecule Crk is required for sustained phosphorylation of Grb2-associated binder 1 and hepatocyte growth factor-induced cell motility of human synovial sarcoma cell lines.
    Watanabe T; Tsuda M; Makino Y; Ichihara S; Sawa H; Minami A; Mochizuki N; Nagashima K; Tanaka S
    Mol Cancer Res; 2006 Jul; 4(7):499-510. PubMed ID: 16849525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD44-independent hepatocyte growth factor/c-Met autocrine loop promotes malignant peripheral nerve sheath tumor cell invasion in vitro.
    Su W; Gutmann DH; Perry A; Abounader R; Laterra J; Sherman LS
    Glia; 2004 Feb; 45(3):297-306. PubMed ID: 14730703
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatocyte growth factor transforms immortalized mouse liver epithelial cells.
    Kanda H; Tajima H; Lee GH; Nomura K; Ohtake K; Matsumoto K; Nakamura T; Kitagawa T
    Oncogene; 1993 Nov; 8(11):3047-53. PubMed ID: 8414505
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatocyte growth factor (HGF) stimulates the tyrosine kinase activity of the receptor encoded by the proto-oncogene c-MET.
    Naldini L; Vigna E; Narsimhan RP; Gaudino G; Zarnegar R; Michalopoulos GK; Comoglio PM
    Oncogene; 1991 Apr; 6(4):501-4. PubMed ID: 1827664
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatocyte growth factor as mitogen, motogen and morphogen, and its roles in organ regeneration.
    Nakamura T
    Princess Takamatsu Symp; 1994; 24():195-213. PubMed ID: 8983076
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HGF/SF and its receptor c-MET play a minor role in the dissemination of human B-lymphoma cells in SCID mice.
    Weimar IS; Weijer K; van den Berk PC; Muller EJ; Miranda N; Bakker AQ; Heemskerk MH; Hekman A; de Gast GC; Gerritsen WR
    Br J Cancer; 1999 Sep; 81(1):43-53. PubMed ID: 10487611
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy.
    Li Y; Lal B; Kwon S; Fan X; Saldanha U; Reznik TE; Kuchner EB; Eberhart C; Laterra J; Abounader R
    Cancer Res; 2005 Oct; 65(20):9355-62. PubMed ID: 16230398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple aspects of the phenotype of mammary epithelial cells transformed by expression of activated M-Ras depend on an autocrine mechanism mediated by hepatocyte growth factor/scatter factor.
    Zhang KX; Ward KR; Schrader JW
    Mol Cancer Res; 2004 Apr; 2(4):242-55. PubMed ID: 15140946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.